Publicaciones (401) Publicaciones de ANTONIO IGNACIO FERNÁNDEZ ORTIZ

2023

  1. Association between hormone therapy and short-term cardiovascular events in women with spontaneous coronary artery dissection

    Revista Espanola de Cardiologia, Vol. 76, Núm. 3, pp. 165-172

  2. Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis

    Diabetes Care, Vol. 46, Núm. 11, pp. 2050-2057

  3. Care of patients with ST-elevation myocardial infarction: an international analysis of quality indicators in the acute coronary syndrome STEMI Registry of the EURObservational Research Programme and ACVC and EAPCI Associations of the European Society of Cardiology in 11 462 patients

    European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 1, pp. 22-37

  4. Clinical Profile and Determinants of Mortality in Patients with Interstitial Lung Disease Admitted for COVID-19

    Journal of Clinical Medicine, Vol. 12, Núm. 11

  5. Coronary angiography in patients without ST-segment elevation following out-of-hospital cardiac arrest. COUPE clinical trial

    Revista Espanola de Cardiologia, Vol. 76, Núm. 2, pp. 94-102

  6. Current Usefulness of Transesophageal Echocardiography in Patients Undergoing Transcatheter Aortic Valve Replacement

    Journal of Clinical Medicine, Vol. 12, Núm. 24

  7. Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years

    Journal of the American College of Cardiology, Vol. 82, Núm. 22, pp. 2069-2083

  8. Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre “real-world practice” registry-based study

    Frontiers in Cardiovascular Medicine, Vol. 10

  9. Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  10. Effects of intravenous lysine acetylsalicylate versus oral aspirin on platelet responsiveness in patients with ST-segment elevation myocardial infarction: the ECCLIPSE-STEMI trial

    Journal of Thrombosis and Thrombolysis, Vol. 55, Núm. 2, pp. 203-210

  11. Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; the HOPE-Covid-19 Registry

    Anti-Infective Agents, Vol. 21, Núm. 2, pp. 66-78

  12. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

    American Journal of Cardiology, Vol. 190, pp. 32-40

  13. Impact of a pulmonary embolism response team initiative on hospital mortality of patients with bilateral pulmonary embolism

    Medicina Clinica, Vol. 160, Núm. 11, pp. 469-475

  14. Impact of annual volume of cases and intensive cardiac care unit availability on mortality of patients with acute myocardial infarction-related cardiogenic shock treated at revascularization capable centres

    European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 7, pp. 422-429

  15. In-hospital outcomes following percutaneous versus surgical intervention in the treatment of aortic stenosis and concomitant coronary artery disease

    Revista Espanola de Cardiologia, Vol. 76, Núm. 8, pp. 600-608

  16. Invasively managed acute coronary syndrome in octogenarian patients: a retrospective cohort study

    REC: CardioClinics, Vol. 58, Núm. 1, pp. 43-54

  17. Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study

    The Lancet Healthy Longevity, Vol. 4, Núm. 9, pp. e487-e498

  18. Mid-Term Angiographic and Intracoronary Imaging Results Following Intracoronary Lithotripsy in Calcified Coronary Artery Disease: Results From Two Tertiary Referral Centres

    Cardiovascular Revascularization Medicine, Vol. 52, pp. 59-66